Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by difficulty in breathing, coughing, and sputum production. It is a leading cause of morbidity and mortality worldwide, necessitating an in-depth understanding of its diagnosis and treatment strategies among healthcare professionals.
Diagnosis of COPD primarily involves identifying symptoms and risk factors, followed by spirometry to confirm airflow obstruction. The presence of a post-bronchodilator FEV1/FVC ratio of less than 0.70 confirms persistent airflow limitation and thus COPD. High-resolution computed tomography (HRCT) can be used in doubtful cases or for phenotyping.
The mainstay of COPD treatment is bronchodilator therapy, including long-acting beta-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs). Inhaled corticosteroids (ICS) are reserved for frequent exacerbators with eosinophilic inflammation. Pulmonary rehabilitation, oxygen therapy, and lifestyle modifications are also integral parts of management.
Acute exacerbations, characterized by an acute worsening of respiratory symptoms, require prompt treatment with bronchodilators, corticosteroids, and antibiotics. Non-invasive ventilation is beneficial in cases of acute respiratory failure. Early hospitalization is recommended for severe exacerbations.
Emerging therapies for COPD include dual bronchodilation, roflumilast for chronic bronchitis phenotype, and endobronchial valves for severe emphysema. Research into novel therapies like stem cell therapy and gene therapy is ongoing.
In conclusion, COPD is a complex disease requiring a comprehensive approach to diagnosis and treatment. A clear understanding of the disease pathology, diagnostic modalities, and treatment strategies is essential for healthcare professionals to manage this condition effectively and improve patient outcomes.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation